Introduction
============

During *in vitro* fertilization (IVF), embryo cryopreservation is useful for surplus embryos after IVF cycles and provides an opportunity to perform an additional embryo transfer without a full IVF cycle \[[@B1]\]. Blastocyst transfer produces better clinical results than cleavage stage embryo transfer because of better embryo selection, an increased implantation rate, and an increased rate of pregnancy \[[@B2][@B3][@B4][@B5][@B6]\]. In recent years, for both fresh IVF cycles and frozen-thawed cycles, single embryo transfer has been an important issue. Frozen-thawed blastocysts share potential advantages with fresh blastocysts. For example, frozen-thawed blastocyst transfer reportedly has a superior pregnancy rate, even though only one or two blastocysts are transferred \[[@B7][@B8][@B9]\]. In this approach, blastocysts are cryopreserved on day 5 or 6 from fresh cycles in which surplus embryos remained. The morphology of the blastocysts on these days varies from early blastocysts to hatched blastocysts. The majority of the blastocyst grading system is based on the degree of blastocoel expansion, the quality of the inner cell mass (ICM), and the appearance of the trophectoderm epithelium (TE) \[[@B10]\]. Briefly, the ICM is graded as A (tightly packed, many cells), B (loosely grouped, several cells), and C (very few cells), and the TE is graded as A (many cells forming a cohesive epithelium), B (few cells forming a loose epithelium), and C (very few large cells). However, within such a grading system, there has been little analysis of the hatching status of the blastocyst. In case of thawing on the day before transfer, as is routinely performed, over 70% of frozen-thawed blastocysts are in the hatching or hatched status on the day of transfer. Thus, a complement to the blastocyst grading system is needed that considers the hatching status.

The morphology prior to freezing is an important factor used to predict embryo viability \[[@B11][@B12]\]. However, the viability of a frozen-thawed blastocyst after transfer remains unknown and the pre-freeze blastocyst grading system is not a suitable indicator for frozen-thawed blastocysts because of a lack of analysis of the hatching pattern, as previously discussed. Therefore, it is necessary to determine the differences in clinical outcomes, not only for the quality of the blastocyst but also for the form of the frozen-thawed blastocyst. Several researchers reported that the combination of pre-freeze and post-thaw morphological parameters could be used to predict live birth outcomes after frozen-thawed blastocyst transfer cycles, and the timing of the post-thaw blastocyst transfer could also be used to predict implantation \[[@B13][@B14]\].

The objective of this study was to study the clinical outcomes of single frozen-thawed blastocyst transfer cycles according to the hatching status of frozen-thawed blastocysts.

Methods
=======

1. Patients, stimulation and embryo culture
-------------------------------------------

A total of 412 cycles of single frozen-thawed transfer cycles performed at the Maria Fertility Hospital from January 2011 to December 2014 were retrospectively analyzed. Female age, causes of infertility, and the number of prior pregnancies were assessed. The causes of infertility before frozen-thawed blastocyst transfer included female factors, male factors, combined factors, and unexplained infertility. Gonadotropin-releasing hormone (GnRH) agonist long protocol or GnRH antagonist protocol was used in fresh cycles. In the GnRH agonist long protocol, patients were down-regulated using GnRH agonist (Superfact, Sanofi-Aventis, Frankfurt, Germany) and stimulation with recombinant follicle stimulating hormone (Gonal F, Merck Serono, Darmstadt, Germany) was started on the third day of menstruation. In GnRH antagonist protocol, ovarian stimulation was started on the third day of menstruation. GnRH antagonist was administered when the leading follicular size is 14 mm or more. When two or more follicles reached 18 mm in diameter, a dose of 10,000 IU human chorionic gonadotropin (hCG; Ovidrel, Merck Serono) was administered in both protocols.

Oocyte retrieval was performed 36 hours after hCG injection. Fertilization was assessed 15 to 18 hours after insemination based on the presence of two pronuclei. The zygotes were washed and cultured in groups of less than 5 in a 50 µL micro-droplet (Sydney IVF Cleavage Medium-CM, COOK, Brisbane, Australia) for 48 hours, and the embryos were subsequently selected for transfer. Some surplus embryos were cultured in a 50 µL micro-droplet (Sydney IVF Blastocyst Medium-BM, COOK) for blastocyst development, and the others were cryopreserved or discarded. All culturing of the embryos was performed in a CO~2~:O~2~:N~2~ (6%:5%:89%) environment.

2. Pre-freezing blastocyst morphology
-------------------------------------

Based on the report by Gardner et al. \[[@B15]\], we graded the blastocyst prior to transfer as A, B, or C according to the degree of blastocoel expansion, the quality of the ICM development, TE appearance and degree of necrosis \[[@B16]\]. The degree of blastocoel expansion was not the important consideration since cryopreservation was performed in the middle expanding stage or afterwards. Therefore, blastocysts were classified mainly by the quality of the ICM and TE appearance. Grade A was numerous tightly packed cells in the ICM and many TE cells organized in the epithelium. Grade B was several loosely packed cells in the ICM and several TE cells in the loose epithelium. Grade C was very few cells in the ICM and few large TE cells in the epithelium.

3. Vitrification and thawing
----------------------------

The vitrification was performed on blastocysts obtained from fresh cycles in which surplus embryos remained on day 5 or 6. The blastocysts were equilibrated in Dulbecco\'s phosphate-buffered saline (DPBS, Thermo, Carlsbad, CA, USA) supplemented with 20% serum substitute supplement (SSS; Irvine Scientific, Santa Ana, CA, USA) and 20% ethylene glycol (EG; Sigma, Palo Alto, CA, USA) for 45 seconds. Then, the equilibrated blastocysts were moved into the vitrification solution consisting of 40% EG, 18% Ficoll (Sigma, Saint Louis, MO, USA) and 0.3 M sucrose (Sigma) dissolved in DPBS supplemented with 20% SSS for 20 seconds. After exposure, 1 or 2 blastocysts were quickly loaded into a thin plastic strip (TPS; SPL Life Science, Seoul, Korea) and plunged into liquid nitrogen \[[@B17][@B18]\]. All steps were performed at room temperature.

Embryos loaded on TPS were transferred for 5 minutes to a warming solution containing 0.5 M sucrose dissolved in DPBS supplemented with 20% SSS followed by transfer to a second warming solution containing 0.125 M sucrose dissolved in DPBS supplemented with 20% SSS for 5 minutes \[[@B19]\]. All steps were performed at room temperature. The embryos were then washed three times in MRC\#46 medium (Biosupply, Seoul, Korea) and cultured in an inner-well dish for further culture at 37℃ in an atmosphere of 6% CO~2~, 5% O~2~ and 89% N~2~. The post-thawing survival of the embryos was observed under an inverted microscope 16 to 20 hours after warming.

4. Post-thaw blastocyst morphology
----------------------------------

Post-thaw blastocysts were also graded using the same reference as Gardner et al. \[[@B15]\]. We graded the blastocyst prior to transfer as A, B, or C by combining the quality of the ICM development, TE appearance and degree of necrosis. Blastocyst morphology prior to transfer was also divided into three groups according to the hatching status. The less-than-expanded blastocyst (≤EdB) group included early, middle expanded, expanded and fully expanded blastocysts, but not the hatching form. The hatching blastocyst (HgB) group included hatching blastocysts, but not hatched blastocysts. The hatched blastocyst (HdB) group included completely hatched blastocysts.

5. Single blastocyst transfer
-----------------------------

In the normal ovulation patients, the endometrium preparation protocol was based on detection of ovulation during a natural cycle. Estrogen, progesterone and luteal hormone were monitored. Some of the normal ovulation patients were administered hCG for accurate synchronization of the endometrium. In patients with irregular cycles, 2.5 to 5 mg letrozole (Femara, Novartis, Basel, Switzerland) was used for endometrium preparation on cycle day 3. Then, follicle growth was monitored by ultrasound. When the follicles reached the criteria of maturation, hCG (10,000 IU) was injected to trigger ovulation. Hormone replacement therapy was also used for endometrial preparation. Two weeks after menstruation, 10 mg of estrogen (estradiol-depot, EVER Pharma Jena GmbH, Jena, Germany) was given. When the endometrium thickness was greater than 8 mm, progesterone (Taiyu progesterone, Taiyu Chemical & Pharmaceutical, Taiwan) was started. The time of thawing embryos and transfer day was determined accordingly.

On the morning of embryo transfer, the thawed blastocysts were evaluated prior to transfer. Pregnancy was assessed by serum hCG concentration at 14 days post embryo transfer. Implantation was confirmed by the presence of a gestational sac. Clinical pregnancy was confirmed by the presence of fetal heart activity at 6 to 8 weeks in pregnancy.

6. Statistics
-------------

The data were examined using *t*-test or chi-square analysis to determine whether the differences in implantation and pregnancy rates were significant for each group. The results were considered statistically significant at *p*-values of \<0.05.

Results
=======

The ≤EdB, HgB, and HdB groups involved 103, 164, and 145 cycles, respectively. There was no significant difference in the average female age of the patients between the groups or differences in the ratio between infertility factors in each group. There was no significant difference in previous pregnancy history between each group. There was no significant difference in blastocyst grade A, B, and C between each group ([Table 1](#T1){ref-type="table"}).

The clinical pregnancy and implantation rates of each group are summarized in [Table 2](#T2){ref-type="table"}. The implantation rate of the ≤EdB, HgB, and HdB groups were 8.7%, 22.0%, and 47.6%, respectively. The clinical pregnancy rate of the ≤EdB, HgB, and HdB groups were 8.7%, 20.1%, and 44.8%, respectively. There was a significant improvement in the clinical pregnancy and implantation rates in the group transferred with hatched blastocysts.

The clinical pregnancy and implantation rates were compared in each group according to the blastocyst quality ([Table 3](#T3){ref-type="table"}). The average female age of each grade of blastocyst in each group was not significantly different. There was no significant difference in the clinical pregnancy rate of each group according to their blastocyst grade. The clinical pregnancy rate of the B and C grades was 12.5% and 8.4% in ≤EdB group, respectively. In the HgB group, the clinical pregnancy rate of the A, B, and C grades was 20.0%, 24.6%, and 17.1%, respectively. In the HdB group, the clinical pregnancy rate of the A, B, and C grades was 46.2%, 47.4%, and 42.7%, respectively. However, there was a significant difference in the clinical pregnancy rate between each group. The clinical pregnancy rate of the HgB group was higher than the ≤EdB group, and that of the HdB group was higher than the HgB group. The pregnancy rate in the HdB groups was similar regardless of the blastocyst quality. There was no significant difference in the implantation rate of each group according to their blastocyst grade. However, there was a significant difference in the implantation rate between each group ([Table 3](#T3){ref-type="table"}).

Discussion
==========

As the technology of preimplantation embryo culture has gradually developed, blastocyst transfer has also been increasing continuously. Generally, because of improved embryo selection, blastocyst transfer is advantageous for successful implantation and pregnancy rate compared to cleavage stage embryo transfer. As blastocyst transfer becomes generalized, there are continuing efforts to transfer a single embryo. Frozen-thawed blastocyst transfer has changed towards protocols that transfer a single embryo. The clinical outcomes of frozen-thawed embryo transfer depend on the quality of the preimplantation embryo before freezing or after thawing \[[@B20]\]. This study explored other parameters in addition to blastocyst quality that can predict the viability of frozen-thawed blastocysts after transfer. In this study, whether single frozen-thawed blastocysts were hatched prior to transfer had a significant impact on pregnancy. The clinical pregnancy rate of the HgB group was higher than the ≤EdB group, and that of the HdB group was higher than the HgB group. Clinical pregnancy in the HdB group was not significantly affected by the quality of the hatched blastocysts; even low-grade blastocysts in the HdB group yielded a pregnancy rate that was higher than high-grade blastocysts of the ≤EdB and HgB groups. Therefore, it is necessary to determine carefully the hatching status when performing single frozen-thawed blastocyst transfers.

The blastocyst grading system is primarily based on the degree of blastocoel expansion, as well as the quality of the ICM and TE. However, this grading system overlooks the hatching status of the blastocyst. In particular, in case of thawing on the day before transfer, as routinely performed, over 70% of frozen-thawed blastocysts are in the hatching or hatched status on the day of transfer. So, when the frozen-thawed blastocysts are graded, the hatching status of the blastocysts should be considered as a parameter before transfer. The morphology was less varied when thawing was performed on the day of transfer. However, thawing the day before or the day of transfer reportedly has no effect on clinical pregnancy rates \[[@B21]\]. The results of this study support thawing on the day before transfer.

We previously reported a mechanical technique for shrinkage using two 29-gauge needles \[[@B22]\]. The hatching rate may be influenced by the formation of a large hole in the zona pellucida (ZP), particularly with 29-gauge needle artificial shrinkage. Partial dissection of the ZP of frozen-thawed human embryos may enhance blastocyst hatching, implantation, and pregnancy rates \[[@B23][@B24]\]. Spontaneous hatching or hatched blastocysts show higher clinical pregnancies, embryo implantation, and live birth rates \[[@B25]\]. The assisted hatching of frozen-thawed blastocysts at the day 3 cleavage stage or of cleavage stage embryos is an effective procedure that can increase the pregnancy rate of human IVF \[[@B26]\]. Therefore, based on previous studies, the hatching or hatched form of blastocysts using assisted hatching may improve the clinical pregnancy. However, the study of assisted hatching of frozen-thawed blastocysts has not yet been performed. Therefore, additional studies are necessary to determine the effect of assisted hatching on frozen-thawed blastocysts.

The most suitable time for the assisted hatching of a frozen-thawed blastocyst is when it shrinks. It is easy to perform assisted hatching because, immediately after thawing, the blastocyst appears separated between the ZP and shrunk cell mass. Because overnight warmed blastocysts feature almost expanded blastocysts or a hatching state, it is difficult to perform assisted hatching.

It is crucial to have confidence in frozen-thawed blastocyst viability for single embryo transfer to be successful. Single embryo transfer is the preferred method for reducing multiple pregnancies when IVF is performed. However, it is a priority to screen viable embryos even during single embryo transfer \[[@B27][@B28]\]. From this point of view, when transferring a single frozen-thawed blastocyst, it is important to determine the quality of that blastocyst. It is also important to ascertain whether hatching may be an important criterion for a frozen-thawed single blastocyst transfer.
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###### Comparison of patients characteristics of the ≤EdB, HgB, and HdB groups
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Values are presented as number or number (%) unless otherwise indicated.

≤EdB group, included early, middle expanded, expanded and fully expanded blastocysts, but not the hatching form; HgB group, included hatching blastocysts, but not hatched blastocysts; HdB group, included completely hatched blastocysts; SE, standard error of the mean.

###### Comparison of clinical outcomes of the ≤EdB, HgB, and HdB groups
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Values are presented as number or number (%).

≤EdB group, included early, middle expanded, expanded and fully expanded blastocysts, but not the hatching form; HgB group, included hatching blastocysts, but not hatched blastocysts; HdB group, included completely hatched blastocysts.

###### Comparison of clinical outcomes of the ≤EdB, HgB, and HdB groups according to blastocyst quality
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Values are presented as mean±SE or number (%).

≤EdB group, included early, middle expanded, expanded and fully expanded blastocysts, but not the hatching form; HgB group, included hatching blastocysts, but not hatched blastocysts; HdB group, included completely hatched blastocysts; SE, standard error of the mean.
